Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances, Challenges and Future Prospects

Urinary incontinence (UI) is a major problem in health care and more than 400 million people worldwide suffer from involuntary loss of urine. With an increase in the aging population, UI is likely to become even more prominent over the next decades and the economic burden is substantial. Among the d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2021-04, Vol.22 (8), p.3981
Hauptverfasser: Schmid, Florian A, Williams, J Koudy, Kessler, Thomas M, Stenzl, Arnulf, Aicher, Wilhelm K, Andersson, Karl-Erik, Eberli, Daniel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 8
container_start_page 3981
container_title International journal of molecular sciences
container_volume 22
creator Schmid, Florian A
Williams, J Koudy
Kessler, Thomas M
Stenzl, Arnulf
Aicher, Wilhelm K
Andersson, Karl-Erik
Eberli, Daniel
description Urinary incontinence (UI) is a major problem in health care and more than 400 million people worldwide suffer from involuntary loss of urine. With an increase in the aging population, UI is likely to become even more prominent over the next decades and the economic burden is substantial. Among the different subtypes of UI, stress urinary incontinence (SUI) is the most prevalent and focus of this review. The main underlying causes for SUI are pregnancy and childbirth, accidents with direct trauma to the pelvis or medical treatments that affect the pelvic floor, such as surgery or irradiation. Conservative approaches for the treatment of SUI are pelvic physiotherapy, behavioral and lifestyle changes, and the use of pessaries. Current surgical treatment options include slings, colposuspensions, bulking agents and artificial urinary sphincters. These treatments have limitations with effectiveness and bear the risk of long-term side effects. Furthermore, surgical options do not treat the underlying pathophysiological causes of SUI. Thus, there is an urgent need for alternative treatments, which are effective, minimally invasive and have only a limited risk for adverse effects. Regenerative medicine is an emerging field, focusing on the repair, replacement or regeneration of human tissues and organs using precursor cells and their components. This article critically reviews recent advances in the therapeutic strategies for the management of SUI and outlines future possibilities and challenges.
doi_str_mv 10.3390/ijms22083981
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8069473</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2520858505</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-e51d2741105177b958d1a47f1f0205a3802ce9d13e85b967ae0140a8833e5d8a3</originalsourceid><addsrcrecordid>eNpdkc1PGzEQxS0EKpD2xhlZ4tJDQv2Z9XJAqlakRKJqpYaz5XhnyUa7drC9oF77l9dRKKScZkb-zdM8P4TOKLnkvCRf2nUfGSOKl4oeoBMqGJsQMi0O9_pjdBrjmhDGmSw_oOO8yKjk7AT9WQQwqQeXsG_wrxQgRnwfWmfCbzx31rvUOnAW8HObVvj7EG0HmYMeV9B1ERtXv4248v3GZz7FK1ytTN6L423TdeAeYEfPhjQEwD-DjxuwKX5ER43pInx6qSN0P7tZVLeTux_f5tXXu4kVlKUJSFqzQlBKJC2KZSlVTY0oGtoQRqThijALZU05KLksp4UBQgUxSnEOslaGj9D1TnczLHuobb4ymE5vQttns9qbVv__4tqVfvBPWpFpKQqeBT6_CAT_OEBMum-jzbaNAz9EzWSOQSpJZEYv3qFrPwSX7WVKqKkquBCZGu8om_8iBmhej6FEb8PV--Fm_HzfwCv8L03-F5PzoN0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2548687344</pqid></control><display><type>article</type><title>Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances, Challenges and Future Prospects</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Schmid, Florian A ; Williams, J Koudy ; Kessler, Thomas M ; Stenzl, Arnulf ; Aicher, Wilhelm K ; Andersson, Karl-Erik ; Eberli, Daniel</creator><creatorcontrib>Schmid, Florian A ; Williams, J Koudy ; Kessler, Thomas M ; Stenzl, Arnulf ; Aicher, Wilhelm K ; Andersson, Karl-Erik ; Eberli, Daniel</creatorcontrib><description>Urinary incontinence (UI) is a major problem in health care and more than 400 million people worldwide suffer from involuntary loss of urine. With an increase in the aging population, UI is likely to become even more prominent over the next decades and the economic burden is substantial. Among the different subtypes of UI, stress urinary incontinence (SUI) is the most prevalent and focus of this review. The main underlying causes for SUI are pregnancy and childbirth, accidents with direct trauma to the pelvis or medical treatments that affect the pelvic floor, such as surgery or irradiation. Conservative approaches for the treatment of SUI are pelvic physiotherapy, behavioral and lifestyle changes, and the use of pessaries. Current surgical treatment options include slings, colposuspensions, bulking agents and artificial urinary sphincters. These treatments have limitations with effectiveness and bear the risk of long-term side effects. Furthermore, surgical options do not treat the underlying pathophysiological causes of SUI. Thus, there is an urgent need for alternative treatments, which are effective, minimally invasive and have only a limited risk for adverse effects. Regenerative medicine is an emerging field, focusing on the repair, replacement or regeneration of human tissues and organs using precursor cells and their components. This article critically reviews recent advances in the therapeutic strategies for the management of SUI and outlines future possibilities and challenges.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms22083981</identifier><identifier>PMID: 33921532</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Abdomen ; Aging ; Bladder ; Childbirth &amp; labor ; Estrogens ; Etiology ; Female ; Health services ; Human tissues ; Humans ; Medical treatment ; Muscle, Skeletal - cytology ; Muscle, Skeletal - transplantation ; Organs ; Pathophysiology ; Pelvic Floor - pathology ; Pelvis ; Pessaries ; Physical Therapy Modalities ; Pregnancy ; Radiation ; Regeneration (physiology) ; Regenerative Medicine ; Stem Cell Transplantation ; Stem cells ; Stem Cells - cytology ; Stem Cells - metabolism ; Tissue engineering ; Trauma ; Urethra - pathology ; Urinary incontinence ; Urinary Incontinence, Stress - metabolism ; Urinary Incontinence, Stress - pathology ; Urinary Incontinence, Stress - therapy ; Urine ; Urogenital system ; Vagina ; Womens health</subject><ispartof>International journal of molecular sciences, 2021-04, Vol.22 (8), p.3981</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-e51d2741105177b958d1a47f1f0205a3802ce9d13e85b967ae0140a8833e5d8a3</citedby><cites>FETCH-LOGICAL-c412t-e51d2741105177b958d1a47f1f0205a3802ce9d13e85b967ae0140a8833e5d8a3</cites><orcidid>0000-0003-0665-3486 ; 0000-0003-2210-6773 ; 0000-0002-0862-5027 ; 0000-0002-1991-5919</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069473/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069473/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33921532$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schmid, Florian A</creatorcontrib><creatorcontrib>Williams, J Koudy</creatorcontrib><creatorcontrib>Kessler, Thomas M</creatorcontrib><creatorcontrib>Stenzl, Arnulf</creatorcontrib><creatorcontrib>Aicher, Wilhelm K</creatorcontrib><creatorcontrib>Andersson, Karl-Erik</creatorcontrib><creatorcontrib>Eberli, Daniel</creatorcontrib><title>Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances, Challenges and Future Prospects</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Urinary incontinence (UI) is a major problem in health care and more than 400 million people worldwide suffer from involuntary loss of urine. With an increase in the aging population, UI is likely to become even more prominent over the next decades and the economic burden is substantial. Among the different subtypes of UI, stress urinary incontinence (SUI) is the most prevalent and focus of this review. The main underlying causes for SUI are pregnancy and childbirth, accidents with direct trauma to the pelvis or medical treatments that affect the pelvic floor, such as surgery or irradiation. Conservative approaches for the treatment of SUI are pelvic physiotherapy, behavioral and lifestyle changes, and the use of pessaries. Current surgical treatment options include slings, colposuspensions, bulking agents and artificial urinary sphincters. These treatments have limitations with effectiveness and bear the risk of long-term side effects. Furthermore, surgical options do not treat the underlying pathophysiological causes of SUI. Thus, there is an urgent need for alternative treatments, which are effective, minimally invasive and have only a limited risk for adverse effects. Regenerative medicine is an emerging field, focusing on the repair, replacement or regeneration of human tissues and organs using precursor cells and their components. This article critically reviews recent advances in the therapeutic strategies for the management of SUI and outlines future possibilities and challenges.</description><subject>Abdomen</subject><subject>Aging</subject><subject>Bladder</subject><subject>Childbirth &amp; labor</subject><subject>Estrogens</subject><subject>Etiology</subject><subject>Female</subject><subject>Health services</subject><subject>Human tissues</subject><subject>Humans</subject><subject>Medical treatment</subject><subject>Muscle, Skeletal - cytology</subject><subject>Muscle, Skeletal - transplantation</subject><subject>Organs</subject><subject>Pathophysiology</subject><subject>Pelvic Floor - pathology</subject><subject>Pelvis</subject><subject>Pessaries</subject><subject>Physical Therapy Modalities</subject><subject>Pregnancy</subject><subject>Radiation</subject><subject>Regeneration (physiology)</subject><subject>Regenerative Medicine</subject><subject>Stem Cell Transplantation</subject><subject>Stem cells</subject><subject>Stem Cells - cytology</subject><subject>Stem Cells - metabolism</subject><subject>Tissue engineering</subject><subject>Trauma</subject><subject>Urethra - pathology</subject><subject>Urinary incontinence</subject><subject>Urinary Incontinence, Stress - metabolism</subject><subject>Urinary Incontinence, Stress - pathology</subject><subject>Urinary Incontinence, Stress - therapy</subject><subject>Urine</subject><subject>Urogenital system</subject><subject>Vagina</subject><subject>Womens health</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkc1PGzEQxS0EKpD2xhlZ4tJDQv2Z9XJAqlakRKJqpYaz5XhnyUa7drC9oF77l9dRKKScZkb-zdM8P4TOKLnkvCRf2nUfGSOKl4oeoBMqGJsQMi0O9_pjdBrjmhDGmSw_oOO8yKjk7AT9WQQwqQeXsG_wrxQgRnwfWmfCbzx31rvUOnAW8HObVvj7EG0HmYMeV9B1ERtXv4248v3GZz7FK1ytTN6L423TdeAeYEfPhjQEwD-DjxuwKX5ER43pInx6qSN0P7tZVLeTux_f5tXXu4kVlKUJSFqzQlBKJC2KZSlVTY0oGtoQRqThijALZU05KLksp4UBQgUxSnEOslaGj9D1TnczLHuobb4ymE5vQttns9qbVv__4tqVfvBPWpFpKQqeBT6_CAT_OEBMum-jzbaNAz9EzWSOQSpJZEYv3qFrPwSX7WVKqKkquBCZGu8om_8iBmhej6FEb8PV--Fm_HzfwCv8L03-F5PzoN0</recordid><startdate>20210412</startdate><enddate>20210412</enddate><creator>Schmid, Florian A</creator><creator>Williams, J Koudy</creator><creator>Kessler, Thomas M</creator><creator>Stenzl, Arnulf</creator><creator>Aicher, Wilhelm K</creator><creator>Andersson, Karl-Erik</creator><creator>Eberli, Daniel</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0665-3486</orcidid><orcidid>https://orcid.org/0000-0003-2210-6773</orcidid><orcidid>https://orcid.org/0000-0002-0862-5027</orcidid><orcidid>https://orcid.org/0000-0002-1991-5919</orcidid></search><sort><creationdate>20210412</creationdate><title>Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances, Challenges and Future Prospects</title><author>Schmid, Florian A ; Williams, J Koudy ; Kessler, Thomas M ; Stenzl, Arnulf ; Aicher, Wilhelm K ; Andersson, Karl-Erik ; Eberli, Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-e51d2741105177b958d1a47f1f0205a3802ce9d13e85b967ae0140a8833e5d8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Abdomen</topic><topic>Aging</topic><topic>Bladder</topic><topic>Childbirth &amp; labor</topic><topic>Estrogens</topic><topic>Etiology</topic><topic>Female</topic><topic>Health services</topic><topic>Human tissues</topic><topic>Humans</topic><topic>Medical treatment</topic><topic>Muscle, Skeletal - cytology</topic><topic>Muscle, Skeletal - transplantation</topic><topic>Organs</topic><topic>Pathophysiology</topic><topic>Pelvic Floor - pathology</topic><topic>Pelvis</topic><topic>Pessaries</topic><topic>Physical Therapy Modalities</topic><topic>Pregnancy</topic><topic>Radiation</topic><topic>Regeneration (physiology)</topic><topic>Regenerative Medicine</topic><topic>Stem Cell Transplantation</topic><topic>Stem cells</topic><topic>Stem Cells - cytology</topic><topic>Stem Cells - metabolism</topic><topic>Tissue engineering</topic><topic>Trauma</topic><topic>Urethra - pathology</topic><topic>Urinary incontinence</topic><topic>Urinary Incontinence, Stress - metabolism</topic><topic>Urinary Incontinence, Stress - pathology</topic><topic>Urinary Incontinence, Stress - therapy</topic><topic>Urine</topic><topic>Urogenital system</topic><topic>Vagina</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schmid, Florian A</creatorcontrib><creatorcontrib>Williams, J Koudy</creatorcontrib><creatorcontrib>Kessler, Thomas M</creatorcontrib><creatorcontrib>Stenzl, Arnulf</creatorcontrib><creatorcontrib>Aicher, Wilhelm K</creatorcontrib><creatorcontrib>Andersson, Karl-Erik</creatorcontrib><creatorcontrib>Eberli, Daniel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schmid, Florian A</au><au>Williams, J Koudy</au><au>Kessler, Thomas M</au><au>Stenzl, Arnulf</au><au>Aicher, Wilhelm K</au><au>Andersson, Karl-Erik</au><au>Eberli, Daniel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances, Challenges and Future Prospects</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2021-04-12</date><risdate>2021</risdate><volume>22</volume><issue>8</issue><spage>3981</spage><pages>3981-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Urinary incontinence (UI) is a major problem in health care and more than 400 million people worldwide suffer from involuntary loss of urine. With an increase in the aging population, UI is likely to become even more prominent over the next decades and the economic burden is substantial. Among the different subtypes of UI, stress urinary incontinence (SUI) is the most prevalent and focus of this review. The main underlying causes for SUI are pregnancy and childbirth, accidents with direct trauma to the pelvis or medical treatments that affect the pelvic floor, such as surgery or irradiation. Conservative approaches for the treatment of SUI are pelvic physiotherapy, behavioral and lifestyle changes, and the use of pessaries. Current surgical treatment options include slings, colposuspensions, bulking agents and artificial urinary sphincters. These treatments have limitations with effectiveness and bear the risk of long-term side effects. Furthermore, surgical options do not treat the underlying pathophysiological causes of SUI. Thus, there is an urgent need for alternative treatments, which are effective, minimally invasive and have only a limited risk for adverse effects. Regenerative medicine is an emerging field, focusing on the repair, replacement or regeneration of human tissues and organs using precursor cells and their components. This article critically reviews recent advances in the therapeutic strategies for the management of SUI and outlines future possibilities and challenges.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33921532</pmid><doi>10.3390/ijms22083981</doi><orcidid>https://orcid.org/0000-0003-0665-3486</orcidid><orcidid>https://orcid.org/0000-0003-2210-6773</orcidid><orcidid>https://orcid.org/0000-0002-0862-5027</orcidid><orcidid>https://orcid.org/0000-0002-1991-5919</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2021-04, Vol.22 (8), p.3981
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8069473
source MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Abdomen
Aging
Bladder
Childbirth & labor
Estrogens
Etiology
Female
Health services
Human tissues
Humans
Medical treatment
Muscle, Skeletal - cytology
Muscle, Skeletal - transplantation
Organs
Pathophysiology
Pelvic Floor - pathology
Pelvis
Pessaries
Physical Therapy Modalities
Pregnancy
Radiation
Regeneration (physiology)
Regenerative Medicine
Stem Cell Transplantation
Stem cells
Stem Cells - cytology
Stem Cells - metabolism
Tissue engineering
Trauma
Urethra - pathology
Urinary incontinence
Urinary Incontinence, Stress - metabolism
Urinary Incontinence, Stress - pathology
Urinary Incontinence, Stress - therapy
Urine
Urogenital system
Vagina
Womens health
title Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances, Challenges and Future Prospects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T10%3A25%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Stress%20Urinary%20Incontinence%20with%20Muscle%20Stem%20Cells%20and%20Stem%20Cell%20Components:%20Chances,%20Challenges%20and%20Future%20Prospects&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Schmid,%20Florian%20A&rft.date=2021-04-12&rft.volume=22&rft.issue=8&rft.spage=3981&rft.pages=3981-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms22083981&rft_dat=%3Cproquest_pubme%3E2520858505%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2548687344&rft_id=info:pmid/33921532&rfr_iscdi=true